Exponent vs RMR
EXPO and RMR side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXPO and RMR compare
Exponent is the larger company, worth 7.7 times as much as RMR ($4.2B against $537M).
On earnings, RMR is cheaper: it trades at 27.5× trailing earnings, against 37.6× for Exponent.
Exponent grew revenue faster over the last twelve months (15.4% versus −8.2% for RMR).
Exponent keeps more of each dollar of sales as profit, with a net margin of 17.4% compared with 1.7% at RMR.
Both pay dividends: Exponent yields 1.4% and RMR 10.7%.
Exponent scores higher on the StockData Score (20 against 8 for RMR), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXPO | RMR |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $537M |
| Share price | $87.31 | $16.75 |
| Change, 1 year | 24.4% | 7.4% |
| Change, 5 years | −30.2% | −53.1% |
| Beta (5Y) | 0.87 | 0.76 |
| Employees | 1,313 | 50K |
| StockData Score | ||
| Total score | 20 (better) | 8 |
| Valuation score | 2 (better) | 0 |
| Growth score | 3 (better) | 0 |
| Performance score | 5 (better) | 3 |
| Health score | 6 (better) | 2 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 37.6× | 27.5× (better) |
| P/S | 6.3× | 0.8× (better) |
| P/B | 13.5× | 2.5× (better) |
| EV/EBITDA | 26.8× | 11.0× (better) |
| P/FCF | 29.5× | – |
| PEG | 20.49 | – |
| FCF yield | 3.4% | – |
| Fair value | $70.23 | $16.58 |
| Margin of safety | −24.3% | −1.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.4% (better) | −8.2% |
| Revenue growth, 5Y average | 7.8% (better) | 1.2% |
| Net income growth (TTM) | 9.4% (better) | −39.2% |
| EPS growth (TTM) | 13.2% (better) | −40.8% |
| EPS growth, 5Y average | 6.0% (better) | −22.3% |
| Profitability | ||
| Operating margin | 21.3% (better) | 6.4% |
| Net margin | 17.4% (better) | 1.7% |
| FCF margin | 21.3% | – |
| Return on equity | 32.3% (better) | 4.9% |
| Return on invested capital | 51.7% (better) | 20.4% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | 3.5× |
| Current ratio | 1.93 (better) | 1.69 |
| Altman Z-score | 9.78 (better) | 3.22 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | 10.7% (better) |
| Payout ratio | 53.2% | 287% |
| Years of dividend growth | 13 | – |
| Dividend growth, 5Y average | 9.6% | – |
| Buyback yield | 4.1% (better) | 0.27% |
| Shareholder yield | 5.5% | 11.0% (better) |
| Ownership | ||
| Held by institutions | 97.8% | 43.9% |
| Held by insiders | 1.3% | 2.2% |
| Insider net buying, 12 months | −$2.7M | – |
| Short interest, % of float | 5.2% | 4.1% |
Go deeper
- EXPO stock overview
- EXPO income statement
- EXPO valuation and score
- RMR stock overview
- RMR income statement
- RMR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.